B. Bandelow et al., PANIC DISORDER - ACCEPTANCE OF THE DIAGNOSTIC ENTITY AND TREATMENT MODALITIES PREFERRED BY GERMAN HEALTH-PROFESSIONALS, European psychiatry, 11(6), 1996, pp. 298-305
A survey of the pharmacological and psychological treatment of panic d
isorder and agoraphobia (PDA) was conducted among 103 physicians, psyc
hologists and psychotherapists. It revealed that the treatments for PD
A preferred by the majority of the respondents are inconsistent with t
he recommendations given in the international literature. Non-psychiat
ric physicians most frequently proposed herbal preparations as a possi
ble treatment (46% of non-psychiatric physicians), followed by homoeop
athic formulations (32%), Tricyclic antidepressants which are recommen
ded as first-line treatment in panic disorder by the literature are pr
eferred by 74% of the psychiatrists, but only by 24% of the non-psychi
atric physicians. Benzodiazepines ate prescribed by twice as many psyc
hiatrists (45%) as non-psychiatric physicians (22%). Beta blockers and
neuroleptics which are not recommended as first-Line treatment in pan
ic disorder are used quite often (psychiatrists: 15%; non-psychiatric
physicians: 26%). Selective serotonin reuptake inhibitors are prescrib
ed by 24% of the psychiatrists, but by only 3% of the non-psychiatric
physicians. Among psychological therapies, psychoanalysis was proposed
as first-line treatment by 44% of all professionals applying psycholo
gical therapies, while cognitive/behaviour therapy was preferred by on
ly 28%, though proof of efficacy exists only for cognitive/behaviour t
herapy. In general, psychologists prefer behaviourally-orientated ther
apy, while physicians mostly propose psychodynamic therapy. One reason
for the fact that the results of controlled studies have little influ
ence an professionals treating PDA patients might be that 40% of the r
espondents do not accept the new classification of the anxiety disorde
rs as introduced in 1980 by the DSM-III.